This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Intellia Therapeutics, Inc., Novartis Ag. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 21 
1 out of 3,978 
Years Active: 2024
Title: The Innovations of Ming-Wei Chen
Introduction
Ming-Wei Chen is a notable inventor based in Winchester, MA, who has made significant contributions to the field of immunooncology. His work focuses on genome editing systems, which have the potential to revolutionize cancer treatment.
Latest Patents
Ming-Wei Chen holds a patent for "Compositions and methods for immunooncology." This invention is directed to genome editing systems, reagents, and methods that enhance the effectiveness of immunooncology therapies.
Career Highlights
Throughout his career, Ming-Wei Chen has worked with prominent companies in the biotechnology sector, including Novartis AG and Intellia Therapeutics, Inc. His experience in these organizations has allowed him to develop innovative solutions in the realm of cancer treatment.
Collaborations
Ming-Wei Chen has collaborated with esteemed colleagues such as Melissa Deck and Glenn Dranoff, contributing to advancements in immunooncology research.
Conclusion
Ming-Wei Chen's work exemplifies the intersection of innovation and healthcare, particularly in the field of immunooncology. His contributions are paving the way for future advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile